Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 24 (4), 253-260
- https://doi.org/10.1016/0165-2478(90)90008-e
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The use of maleimidocaproyloxysuccinimide to prepare malarial peptide carrier immunogens immunogenicity of the linking regionJournal of Immunological Methods, 1989
- Adjuvants for anti-parasite vaccinesParasitology Today, 1989
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- An epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparumMolecular and Biochemical Parasitology, 1988
- Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoproteinImmunology & Cell Biology, 1987
- Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunityVaccine, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- A method for preparing β-hCG COOH peptide-carrier conjugates of predictable compositionMolecular Immunology, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagentAnalytical Biochemistry, 1968